Results 171 to 180 of about 59,431 (239)

Gemcitabine plus selinexor in selective advanced sarcomas: a phase I of the Spanish group for research on sarcoma study. [PDF]

Nat Commun
Martin-Broto J, Casado A, Marquina G, Redondo A, Martinez-Trufero J, Valverde C, Gutierrez A, Bernabeu D, Ortega L, Merino J, Ramos R, Ledesma P, Mondaza-Hernandez JL, Moura DS, Hindi N.   +14 more
europepmc   +1 more source

The therapeutic potential of <i>Ziziphus jujuba</i> in colorectal cancer: An <i>in-vitro</i> study. [PDF]

Avicenna J Phytomed
Pourali G, Moetamani-Ahmadi M, Alaei M, Fiuji H, Fathi A, Maftooh M, Khazaei M, Ferns GA, Hassanian SM, Avan A.   +9 more
europepmc   +1 more source

Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer. [PDF]

Neoplasia
Geisen ME, Tessmann JW, Kelson CO, He D, Wang C, Faisal ASM, Beswick EJ, Baca Y, Rock S, Kolesar JM, Zaytseva YY.   +10 more
europepmc   +1 more source

Striking at Survivin: YM-155 Inhibits High-Risk Neuroblastoma Growth and Enhances Chemosensitivity. [PDF]

Cancers (Basel)
Rouse DC, Chilamakuri R, Agarwal S.
europepmc   +1 more source

Editorial: Advancements and challenges in veterinary oncology. [PDF]

Front Vet Sci
Queiroga F, Horta RDS, Giuliano A, Dagli MLZ.   +3 more
europepmc   +1 more source

Narciclasine triggers apoptosis in osteosarcoma cells via JNK-mediated extrinsic and intrinsic pathways. [PDF]

Int J Med Sci
Yang JS, Chou CH, Chen PN, Hsieh YH, Tang CH, Yang SF, Lu KH.   +6 more
europepmc   +1 more source

Survivin Is a Central Mediator of Cell Proliferation in HPV-Negative Head and Neck Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Zhu J, An J, Hu E, Rosenblatt G, Berner G, Roy A, Kawachi N, Shrivastava N, Mehta V, Segall JE, Prystowsky MB, Ow TJ.   +11 more
europepmc   +1 more source

The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis. [PDF]

Medicine (Baltimore)
Yuan K, Bai Y, Chen S, Shi Y, Yu M, Zhang K, Zhu L, Li S.   +7 more
europepmc   +1 more source

Computational and experimental discovery of peptide inhibitors targeting survivin for therapeutic potential in cancer. [PDF]

Sci Rep
Ahmadi SF, Arab SS, Samadikhah H.
europepmc   +1 more source

[Corrigendum] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin‑related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells. [PDF]

Oncol Rep
Yin Y, Tang L, Shi L.
europepmc   +1 more source